1015-16:  Pharmacology of Medical Cannabis

Introduction to the pharmacodynamics and pharmacokinetics of medical cannabis, review of current research on its action in multiple organ systems, discussion of potential drug-drug interactions, use vs. abuse, and considerations in providing health risk and benefit advice to clients.

Presenter: Caroline Tassey, MSN PMHNP-BC

Disclosures:  The presenters and planners have no conflict of interest or commercial support to disclose.  Off-label uses will be discussed during this presentation. 

Session Length:  1 Hour 48 minutes

Target Audience:  APRN

Session Objectives
Upon completion of this presentation, the participant will be able to:
1.  Identify the physiologic endocannaboids and their receptors and state their function in the brain and immune system. 
2.  Identify the principal phyto-cannabinoids in the cannabis plant and their receptor sites and explain the entourage effect.
3.  List at least one positive and one negative action of cannabis in at least 3 organ systems and discuss potential uses in disease states.

Keywords: Cannabis, Cannabinoids, Practice, Psychopharmacology, Substance Use

Continuing Nursing Education
1.75 contact hours.  * In order to receive contact hours, you must: Listen to presentation, complete an evaluation, and earn a passing score on the post-test before the expiration date. You will have 5 tries to correctly answer the questions on the post-test and a score of 80% is required to pass.  Once you have passed and completed an evaluation, the certificate will be generated online, available for you to print immediately.  You cannot earn credit unless all steps are completed.

The American Psychiatric Nurses Association is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation.

Originally Presented
APNA 30th Annual Conference
Hartford, Connecticut
Wednesday, October 19
7:15am - 9:15am

Release Date: December 16, 2016
The contact hours for this session expire:  November 30, 2019